Literature DB >> 21629288

Anticancer drugs: Now get out of that....

Nicola McCarthy.   

Abstract

Year:  2011        PMID: 21629288     DOI: 10.1038/nrd3471

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN: 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Conformational control inhibition of the BCR-ABL1 tyrosine kinase, including the gatekeeper T315I mutant, by the switch-control inhibitor DCC-2036.

Authors:  Wayne W Chan; Scott C Wise; Michael D Kaufman; Yu Mi Ahn; Carol L Ensinger; Torsten Haack; Molly M Hood; Jennifer Jones; John W Lord; Wei Ping Lu; David Miller; William C Patt; Bryan D Smith; Peter A Petillo; Thomas J Rutkoski; Hanumaiah Telikepalli; Lakshminarayana Vogeti; Tony Yao; Lawrence Chun; Robin Clark; Peter Evangelista; L Cristina Gavrilescu; Katherine Lazarides; Virginia M Zaleskas; Lance J Stewart; Richard A Van Etten; Daniel L Flynn
Journal:  Cancer Cell       Date:  2011-04-12       Impact factor: 31.743

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.